Yesterday, FuelCell Energy (NASDAQ:FCEL) saw a 9.8% drop after announcing a common stock offering of up to $200 million. Corcept (NASDAQ:CORT) plummeted by 51.4% following the FDA’s rejection of its New Drug Application for relacorilant. On the other hand, PacBio (NASDAQ:PACB) surged 6.1% after ARK Invest purchased a significant amount of its shares. Will you buy FuelCell Energy, Corcept, or PacBio? Access our full analysis reports for each company to make an informed decision.

Read more at Barchart: FuelCell Energy, Corcept, and PacBio